Internal Medicine, Gastroenterology · Metuchen, NJ
NPI
1417986167
Since 2006
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
205 Bridge St
Metuchen, NJ, 08840
Phone (732) 888-4800
Groups this clinician bills Medicare through
Medicare paid, 2024
$122K
1,085 services
Medicare patients, 2024
289
Average age 70
Drug cost, 2024
$1.4M
2,561 prescriptions
Company payments, 2025
$5,053
From 24 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Srinivas S Vasireddi was code 99213 (office e&m - established), 536 times for 228 patients. In total Srinivas S Vasireddi billed 1,085 services in 19 codes, and Medicare paid $122K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-07-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 536 | 228 | $63.04 | $34K |
| 91200 Standard X-ray | Office | 141 | 103 | $8.36 | $1,179 |
| 99203 Office E&M - New | Office | 89 | 89 | $83.93 | $7,469 |
| 43239 Upper GI Endoscopy | Office | 83 | 83 | $318.78 | $26K |
| 99214 Office E&M - Established | Office | 63 | 57 | $108.94 | $6,863 |
| 45384 Colonoscopy - Lesion Removal | Office | 39 | 39 | $415.53 | $16K |
| 45385 Colonoscopy - Lesion Removal | Office | 30 | 30 | $383.53 | $12K |
| 45380 Lower GI Endoscopy - Other | Office | 28 | 28 | $367.95 | $10K |
| 99204 Office E&M - New | Office | 20 | 20 | $137.72 | $2,754 |
| 99232 Hospital E&M - Subsequent | Facility | 20 | 15 | $62.89 | $1,258 |
By year: 2022 $130K for 807 services; 2023 $136K for 1,009 services; 2024 $122K for 1,085 services.
Medicare prescription drug claims, 2024
In 2024, the drug Srinivas S Vasireddi prescribed most often to Medicare patients was Famotidine, with 463 prescriptions and refills. In total Srinivas S Vasireddi wrote 2,561 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Famotidine Generic | 463 | 1,156 | 174 | $4,200 |
| Pantoprazole Sodium Generic | 326 | 828 | 131 | $3,627 |
| Omeprazole Generic | 247 | 577 | 75 | $2,825 |
| Creon Lipase/Protease/Amylase | 173 | 262 | 46 | $548K |
| Sucralfate Generic | 155 | 319 | 56 | $5,288 |
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 130 | 130 | 124 | $8,207 |
| Ursodiol Generic | 97 | 135 | 24 | $42K |
| Voquezna Vonoprazan Fumarate | 72 | 80 | 18 | $49K |
| Gavilyte-G Peg3350/Sod Sulf,bicarb,cl/Kcl | 68 | 68 | 67 | $1,055 |
| Balsalazide Disodium Generic | 58 | 77 | 18 | $3,498 |
| Zenpep Lipase/Protease/Amylase | 56 | 65 | 13 | $223K |
| Lactulose Generic | 52 | 72 | 33 | $1,183 |
| Colesevelam Hcl Generic | 51 | 67 | 15 | $2,351 |
| Dicyclomine Hcl Generic | 49 | 63 | 23 | $647 |
| Metronidazole Generic | 46 | 46 | 41 | $264 |
Brand drugs: 608 claims; generic drugs: 1,953 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Srinivas S Vasireddi $5,053 ($5,053 in general payments such as food, travel and fees) from 24 companies. The largest payer was Madrigal Pharmaceuticals with $1,423.
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals MDGL | 103 | $1,423 |
| Abbvie Inc. ABBV | 52 | $745 |
| Phathom Pharmaceuticals, Inc. PHAT | 50 | $462 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 31 | $440 |
| Lilly USA, LLC LLY | 18 | $265 |
| Intercept Pharmaceuticals, Inc. | 8 | $265 |
| Vivus LLC | 15 | $224 |
| Pfizer Inc. PFE | 19 | $222 |
| Janssen Biotech, Inc. JNJ | 11 | $188 |
| Genzyme Corporation SNY | 8 | $158 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.